Posts Tagged :

Shields Care Model

Analysis of Glucagon-Like Peptide-1 Agonist Trends Within An Integrated Health System Specialty Pharmacy 70 70 Shields Health Solutions

Analysis of Glucagon-Like Peptide-1 Agonist Trends Within An Integrated Health System Specialty Pharmacy

  According to the CDC, approximately 38 million Americans have diabetes (about 1 in 10) and approximately 90-95% of those have type 2 diabetes. GLP-1 and GLP-1/GIP agonists are now recognized…

Shields Outcomes 2024 Report 70 70 Shields Health Solutions

Shields Outcomes 2024 Report
This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
How Health System Specialty Pharmacy Can Support Pediatric Diabetes Patients 204 115 Shields Health Solutions

How Health System Specialty Pharmacy Can Support Pediatric Diabetes Patients
This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
How Spartanburg Regional Healthcare System Increased Patient Satisfaction by 24% with Specialty Pharmacy Services 204 115 Shields Health Solutions

How Spartanburg Regional Healthcare System Increased Patient Satisfaction by 24% with Specialty Pharmacy Services
This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
Exploring AI’s Potential to Transform Specialty Pharmacy 204 115 Shields Health Solutions

Exploring AI’s Potential to Transform Specialty Pharmacy
This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
Clinical Outcomes in Cystic Fibrosis Patients Enrolled in an Integrated Health System Specialty Pharmacy Care Model 216 115 Shields Health Solutions

Clinical Outcomes in Cystic Fibrosis Patients Enrolled in an Integrated Health System Specialty Pharmacy Care Model

This poster presents an evaluation of outcomes in cystic fibrosis (CF) patients within a health system specialty pharmacy care model by comparing them to established benchmarks.      

The Impact of Specialty Pharmacy on Clinician Allocation 204 115 Shields Health Solutions

The Impact of Specialty Pharmacy on Clinician Allocation
This white paper describes how an integrated specialty pharmacy can help alleviate the burden on health systems and their patients.
Pediatric Patients Benefit from An Integrated Specialty Pharmacy Care Model 204 115 Shields Health Solutions

Pediatric Patients Benefit from An Integrated Specialty Pharmacy Care Model
This white paper describes how an integrated specialty pharmacy can help alleviate the burden on health systems and their patients.
The Challenge of Financial Toxicity in Cancer Care: a Focus on Oral Oncology 204 115 Shields Health Solutions

The Challenge of Financial Toxicity in Cancer Care: a Focus on Oral Oncology
This white paper describes how an integrated specialty pharmacy can help alleviate the burden on health systems and their patients.
Shields Health Solutions Consistently Demonstrates Superior Clinical Outcomes 204 115 Shields Health Solutions

Shields Health Solutions Consistently Demonstrates Superior Clinical Outcomes
Shields demonstrates its unwavering commitment to specialty patient care through our latest patient outcomes in key disease states such as hepatitis C, HIV, rheumatoid arthritis (RA), and multiple sclerosis (MS).